Detalhe da pesquisa
1.
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Breast Cancer Res
; 21(1): 55, 2019 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036035
2.
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.
Hum Mutat
; 39(12): 2040-2046, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30216591
3.
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Breast Cancer Res
; 20(1): 7, 2018 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368626
4.
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
Int J Cancer
; 144(7): 1761-1763, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474284
5.
RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families.
Breast Cancer Res
; 15(6): R120, 2013 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24359560
6.
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer.
Breast Care (Basel)
; 17(2): 199-207, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702495
7.
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.
J Natl Cancer Inst
; 114(4): 565-570, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963005
8.
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
Cancers (Basel)
; 14(14)2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884425
9.
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.
J Natl Cancer Inst
; 113(7): 893-899, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33372680
10.
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial.
JAMA Oncol
; 6(5): 744-748, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32163106
11.
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Cancer Med
; 7(4): 1349-1358, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29522266